Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1/2</i> Pathogenic Variant CarriersMiranda P. Steenbeek, Joanne A. de Hullu, Marc van Beurden et al.|JAMA Oncology|2021Cited by 78
Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelinesR. F. M. Vermeulen, Marc van Beurden, Catharina M. Korse et al.|Climacteric|2019Cited by 37
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H.D. van Bommel, Joanne A. de Hullu, Miranda P. Steenbeek et al.|Supportive Care in Cancer|2022Cited by 9
Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomyLennart J. van Winden, Huub H. van Rossum, R. F. M. Vermeulen et al.|Journal of the Endocrine Society|2022Cited by 8
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P. Steenbeek, Rosella Hermens, Majke H.D. van Bommel et al.|Gynecologic Oncology|2021Cited by 6